We concluded that c-myc/miR-150/EPG5 axis-mediated dysfunction of autophagy contributed to NSCLC development, suggesting a potentially novel diagnostic and therapeutic target for NSCLC. The gene discussed is EPG5; the disease is non-small cell lung carcinoma.